Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Robert Busby(Ironwood Pharmaceuticals (United States)), Marco M. Kessler(Ironwood Pharmaceuticals (United States)), Wilmin Bartolini(Ironwood Pharmaceuticals (United States)), Alexander P. Bryant(Ironwood Pharmaceuticals (United States)), Gerhard Hannig(Ironwood Pharmaceuticals (United States)), Carolyn S. Higgins(Ironwood Pharmaceuticals (United States)), Robert Solinga(Ironwood Pharmaceuticals (United States)), Jenny Tobin(Ironwood Pharmaceuticals (United States)), James Wakefield(Ironwood Pharmaceuticals (United States)), Caroline B. Kurtz(Ironwood Pharmaceuticals (United States)), Mark G. Currie(Ironwood Pharmaceuticals (United States))
Cited by 136
Abstract
Related Papers
No related papers found
Powered by citation graph analysis